tiprankstipranks
Trending News
More News >
Arcadia Biosciences (RKDA)
NASDAQ:RKDA

Arcadia Biosciences (RKDA) Stock Statistics & Valuation Metrics

Compare
472 Followers

Total Valuation

Arcadia Biosciences has a market cap or net worth of $6.77M. The enterprise value is $1.22M.
Market Cap$6.77M
Enterprise Value$1.22M

Share Statistics

Arcadia Biosciences has 1,367,040 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding1,367,040
Owned by Insiders2.49%
Owned by Institutions0.02%

Financial Efficiency

Arcadia Biosciences’s return on equity (ROE) is -1.13 and return on invested capital (ROIC) is -32.90%.
Return on Equity (ROE)-1.13
Return on Assets (ROA)-0.52
Return on Invested Capital (ROIC)-32.90%
Return on Capital Employed (ROCE)-0.33
Revenue Per Employee560.56K
Profits Per Employee-782.00K
Employee Count9
Asset Turnover0.37
Inventory Turnover3.28

Valuation Ratios

The current PE Ratio of Arcadia Biosciences is -1.15. Arcadia Biosciences’s PEG ratio is -0.03.
PE Ratio-1.15
PS Ratio0.00
PB Ratio0.85
Price to Fair Value1.30
Price to FCF-0.55
Price to Operating Cash Flow-0.55
PEG Ratio-0.03

Income Statement

In the last 12 months, Arcadia Biosciences had revenue of 5.04M and earned -7.04M in profits. Earnings per share was -5.16.
Revenue5.04M
Gross Profit2.08M
Operating Income-3.65M
Pretax Income-4.31M
Net Income-7.04M
EBITDA-7.50M
Earnings Per Share (EPS)-5.16

Cash Flow

In the last 12 months, operating cash flow was -9.63M and capital expenditures -16.00K, giving a free cash flow of -9.64M billion.
Operating Cash Flow-9.63M
Free Cash Flow-9.64M
Free Cash Flow per Share-7.05

Dividends & Yields

Arcadia Biosciences pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share
Dividend Yield
Payout RatioN/A
Free Cash Flow Yield
Earnings Yield

Stock Price Statistics

Beta1.53
52-Week Price Change74.04%
50-Day Moving Average3.69
200-Day Moving Average3.90
Relative Strength Index (RSI)70.34
Average Volume (3m)14.58K

Important Dates

Arcadia Biosciences upcoming earnings date is Aug 13, 2025, TBA Not Confirmed.
Last Earnings DateMay 8, 2025
Next Earnings DateAug 13, 2025
Ex-Dividend Date

Financial Position

Arcadia Biosciences as a current ratio of 3.61, with Debt / Equity ratio of 2.49%
Current Ratio3.61
Quick Ratio3.25
Debt to Market Cap0.02
Net Debt to EBITDA0.55
Interest Coverage Ratio0.00

Taxes

In the past 12 months, Arcadia Biosciences has paid 8.00K in taxes.
Income Tax8.00K
Effective Tax Rate>-0.01

Enterprise Valuation

Arcadia Biosciences EV to EBITDA ratio is -0.53, with an EV/FCF ratio of -0.41.
EV to Sales0.79
EV to EBITDA-0.53
EV to Free Cash Flow-0.41
EV to Operating Cash Flow-0.41

Balance Sheet

Arcadia Biosciences has $4.24M in cash and marketable securities with $155.00K in debt, giving a net cash position of -$4.09M billion.
Cash & Marketable Securities$4.24M
Total Debt$155.00K
Net Cash-$4.09M
Net Cash Per Share-$2.99
Tangible Book Value Per Share$4.54

Margins

Gross margin is 37.67%, with operating margin of -72.31%, and net profit margin of -139.50%.
Gross Margin37.67%
Operating Margin-72.31%
Pretax Margin-85.41%
Net Profit Margin-139.50%
EBITDA Margin-148.64%
EBIT Margin-150.88%

Analyst Forecast

The average price target for Arcadia Biosciences is $12.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$12.00
Price Target Upside141.94% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast-2.81%
EPS Growth Forecast72.03%

Scores

Smart ScoreN/A
AI Score58
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis